ORA, Inc.

Also known as: H. Jerome Crampton | Ophthalmic Research Associates, Andover, MA | Ophthalmic Research Associates, Inc. | Ophthalmic Research Associates, North Andover, MA | ORA, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2005

Last known activity

Aug 1, 2025

Timeline

1980s

Jun 1, 1985
ORA, Inc.— Founded

Drugs by trial phase (49 distinct, 66 trials)

Phase 4 (11 own, 0 via acquisition)

Phase 3 (14 own, 0 via acquisition)

Phase 2 (21 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

NCT07068958Lead sponsorPhase 2Aug 1, 2025
NCT06329791CollaboratorPhase 3May 28, 2024
NCT06178679Lead sponsorPhase 3Jan 2, 2024
NCT06128369CollaboratorPhase 3Dec 31, 2023
NCT05896670CollaboratorPhase 2Nov 29, 2023
NCT05984927CollaboratorPhase 1/Phase 2Sep 8, 2023
NCT05936489CollaboratorPhase 1Jul 6, 2023
NCT05759208CollaboratorPhase 2Apr 28, 2023
NCT05728944CollaboratorPhase 3Apr 24, 2023
NCT05753189CollaboratorPhase 3Feb 21, 2023
NCT05656027CollaboratorPhase 3Dec 19, 2022
NCT05431543CollaboratorPhase 2Aug 6, 2022
NCT05411367Study directorPhase 3Jul 28, 2022
NCT05411367CollaboratorPhase 3Jul 28, 2022
NCT05372107CollaboratorPhase 1Jun 13, 2022

Details

Founded: Andover, MA, US Jun 1, 1985
Last known activity: Aug 1, 2025

Notes

CRO